SIGNIFOR sol inj 0.9 mg/ml 30 amp 1 ml
7680612540052
CH-61254
H01CB05
07.16.2.
Reimbursement limitations:
SIGNIFOR
Pour le traitement de patients atteints de maladie de Cushing, lorsque toutes les possibilités thérapeutiques …
1 / 3
google
Details
- Product number
- 6125403
- CPT
- -
- Packaging group
- 30
- Unit
- Ampulle(n)
- Composition
- pasireotidum 0.9 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Signifor 0.9 mg/1 ml, Injektionslösung
Injektionslösung
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.9 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2206.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2013
Authorization holder
RECORDATI AG
4057 Basel
Authorization information
- Swissmedic authorization number
- 61254
- Drug name
- Signifor, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- H01CB05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/11/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIGNIFOR sol inj 0.9 mg/ml 30 amp 1 ml
- Description (DE)
- SIGNIFOR Inj Lös 0.9 mg/ml 30 Amp 1 ml
- Market launch
- 02/11/2012
- Narcotic (BTM)
- No